In the fast paced world of Indian pharmaceuticals, leadership changes can signal big shifts in strategy and growth. Today, Cipla Limited one of India’s most respected drugmakers officially entered a new chapter. Following a Board meeting on March 30, 2026 company announced that long time Managing Director and Global CEO Umang Vohra has stepped down effective April 1, 2026.
A third year B.Pharma student named Ch. Suvarshini lost her life after jumping from the hostel building at SIR CR Reddy College of Pharmaceutical Science. This incident occurred shortly after a farewell party where she was allegedly forced to dance and teased by friends. She spoke to her family before the fall and she was immediately rushed to hospital but could not be saved.
Read MoreOn March 21,2026 company disclosed that it received a draft tax assessment order proposing additions of ₹570.51 crore to its income for FY 2022–23.
Read MoreJB Pharma has been hit with a ₹80.81 lakh GST penalty, raising questions about tax compliance in the pharma industry. What led to this action, and should investors be concerned? Here’s a complete breakdown of the case and its implications.
Read MoreIn a strategic move, Mankind Pharma has acquired the rights of Roche’s Rivotril brand in India. The deal strengthens its presence in CNS therapies and is expected to improve availability and affordability of clonazepam for patients with epilepsy and related conditions.
Read MoreA man posing as a Drug Inspector was arrested in Jaipur for extorting chemists using hidden camera evidence and running a fake government job scam. Police are investigating the case as more victims come forward.
Read MorePunjab Vigilance Bureau arrested FDA Drug Inspector Ramandeep Gupta on March 7, 2026, in Bathinda for accepting ₹1 lakh bribe from Radinex Life Sciences’ director. Gupta had sealed the pharma facility (since 2020) and demanded ₹2 lakh monthly to reopen it. VB set a trap after verifying claims, charging him under Prevention of Corruption Act.
Read More
